According to the most recent 13F filing that Paulson Wealth Management Inc. submitted with the Securities and Exchange Commission, the company made a fresh investment in Walgreens Boots Alliance, Inc. (NASDAQ: WBA) during the third quarter of this year. This information was provided in the company’s earnings. Reportnagement Inc. submitted to the Securities and Exchange Commission; the company made a fresh investment in Walgreens Boots Alliance, Inc. (NASDAQ: WBA) during the third quarter of this year. This information was provided in the company’s earnings report. The corporation spent approximately $247,000 to acquire 7,858 shares of the pharmacy operator’s stock, bringing the total cost of the transaction to approximately $247,000.
Hedge funds and various other types of institutional investors have adjusted the positions they currently hold in WBA throughout the past few months. The first three months of 2018 saw Renaissance Technologies LLC make a 179.9% increase in its ownership stake in Walgreens Boots Alliance. After making an additional purchase of 1,227,700 shares during the relevant period, Renaissance Technologies LLC now owns 1,910,000 shares of the drugstore operator’s stock. These shares have a current value of $85,511,000. River Road Asset Management LLC’s ownership stake in Walgreens Boots Alliance rose by 253.1% during the company’s second fiscal quarter after the stock price increased. The pharmacy operator’s stock, valued at $42,637,000, is currently owned by River Road Asset Management LLC. The most recent fiscal quarter saw the acquisition of an additional 806,380 shares by the company, bringing the total number of shares held by the company to 1,124,975. During the second quarter, AustralianSuper Pty Ltd acquired another 90.5% of Walgreens Boots Alliance stock, bringing the company’s total holdings to 100%.AustralianSuper Pty Ltd now owns 1,541,330 shares of the drugstore operator’s stock, valued at $58,416,000, after purchasing an additional 732,202 shares during the most recent quarter. These shares were acquired to bring the total number of shares owned by the company up to 1,541,330. During the first three months of the year, Cowa LLC increased its ownership of Walgreens Boots Alliance shares by a total of 10,678.3%. Following the purchase of 689,497 additional shares during the most recent fiscal quarter, Cowa LLC now owns a total of 695,954 shares of the drugstore operator’s stock, which has a value of $312,000. This brings the total number of shares owned by Cowa LLC up to 695,954, valued at $312,000 (up from 689,497). Last but certainly not least, Alps Advisors Inc. increased the percentage of its ownership stake in Walgreens Boots Alliance by 12,930.8% during the second quarter. Alps Advisors Inc. now has 601,630 shares of the drugstore operator’s stock, valued at $22,802,000, after purchasing an additional 597,013 shares during the most recent quarter. Institutional investors and hedge funds own 56.71% of the company’s stock combined. Hedge funds make up the rest of the ownership.
On Wednesday, NASDAQ WBA dropped $0.32, ending the day at $36.01. Trading volume was significantly lower than usual, with only 91,226 shares changing hands rather than 8,362,999 shares. The company has a market capitalization of $31.06 billion, a price-to-earnings ratio of -10.56, a price-to-earnings-to-growth ratio of 1.63, and a beta value of 0.75. All of these metrics point to the company’s strong performance. The debt-to-equity ratio is 0.32, the current ratio is 0.70, and the quick ratio is 0.36. All of these figures are presented in ratio form. The stock’s 50-day moving average is currently at $39.23, while its 200-day moving average is at $37.30. Both of these moving averages are above the stock’s current price. Walgreens Boots Alliance, Inc. hit a low point over the past 52 weeks of $30.39, while the company hit a high point over the past 52 weeks of $54.35.
On January 5, a report detailing the performance of Walgreens Boots Alliance (NASDAQ: WBA) was made available to the public. The pharmacy chain reported $1.16 per share earnings for the quarter, which is $0.02 higher than the consensus estimate of $1.14 per share. The company reported sales for the quarter that were significantly higher than the average prediction of $33.04 billion, which was $33.04 billion. The company’s sales totaled $33.38 billion. Although Walgreens Boots Alliance had a positive return on equity of 13.57%, the company’s net margin was -2.24%, which indicates that the company was experiencing a financial loss. A decrease in quarterly revenue of 1.5% was experienced by Walgreens Boots Alliance when compared to the results achieved during the same period in the previous year. The company generated $1.68 per share during the previous year. Profits of 4.5 cents per share are what market analysts anticipate Walgreens Boots Alliance, Inc., will bring in during this year, and those forecasts come from the company.
In addition, the company recently announced and paid a quarterly dividend, which was paid out on December 12 of this year. The dividend was declared and paid out just recently. On Tuesday, November 15, dividend payments were sent out to stockholders whose information was already on file this year. The dividend was declared and paid out just recently. On Tuesday, November 15, dividend payments were sent out to stockholders whose information was already on file. The amount of each dividend payment was $0.48 per share. The date of November 14, a Monday, was the date that shareholders were required to pay the dividend out of their funds. This results in a dividend yield of 5.33 percent and an annual dividend payment of 1.92 dollars. Walgreens Boots Alliance presently has a dividend payout ratio (DPR) of 55.81% below zero.
The individual reports each brokerage firm has compiled on WBA have recently been made available to the public. In a research note distributed on Wednesday, October 19, Royal Bank of Canada decreased their price target for Walgreens Boots Alliance from $42.00 to $36.00. In addition, the research note gave the company a rating of “sector perform.” Morgan Stanley reaffirmed an “underweight” rating on shares of Walgreens Boots Alliance and set a target price of $39.00 for the company’s stock in a research note published on Wednesday, November 23. The research note was about the company’s stock. On Wednesday, October 5, the recommendation that StockNews.com had previously given for Walgreens Boots Alliance was changed from “buy” to “hold.” In a research report released on Friday, November 11, Deutsche Bank Aktiengesellschaft raised their price objective on Walgreens Boots Alliance from $41.00 to $50.00 and upgraded the company from a “hold” rating to a “buy” rating. Both of these changes were made concerning Walgreens Boots Alliance. It was stated in a study that was made public by Trust Financial on Tuesday, November 8, that the target price for Walgreens Boots Alliance had been raised from $38.00 to $44.00. This increase came about as a result of the study’s findings. The stock has been recommended to sell by one of the equity research analysts, a recommendation to hold it by ten, and a recommendation to buy by three of the equity research analysts. The current recommendation for Walgreens Boots Alliance is “Hold,” and the current consensus price objective for the company is $43.62 per share, as reported by Bloomberg.
In other news, Executive Vice President Kevin M. Ban sold 10,303 company stock on November 18. This was reported in the news on November 18. This information was disclosed in a prior update. The total amount obtained from the sale of the shares was $414,077.57, which works out to a price of $40.19 for each share. The executive vice president is now the owner of 27,916 business shares, which have a combined value of $1,121,944.04 as a direct result of the transaction. You will be taken to a document submitted to the Securities and Exchange Commission if you click the link. This document contains information and an explanation about the transaction that was just completed. On November 17, Director Nancy M. Schlichting decided to sell 16,570 shares of the company’s stock. This piece of information is relevant to this topic of discussion. The number of shares traded had a total value of $660,977.30, with the average price per share coming in at $39.89. This resulted in the accumulation of cash. The director is now the direct owner of 5,515 company shares, which have a value of $219,993.35, as a direct result of the transaction. If you follow this link, you will be taken to the filing submitted to the Securities and Exchange Commission, where the transaction was discussed, and it will take you there immediately.
On top of that, Executive Vice President Kevin M. Ban sold 10,303 shares of the company’s stock on Friday, November 18. The total amount obtained from the sale of the shares was $414,077.57, which works out to a price of $40.19 for each share. Following the completion of the sale, the executive vice president will now have 27,916 shares in the company, each of which is currently valued at 1,121,944.04 dollars. Disclosures that are related to the sale might be found in this section of the website. The company’s employees and other company insiders hold a combined total of 17.40% shares.